Telmisartan/Amlodipine/Rosuvastatin Tablets 80/5/10 mg

Adult dose

Take one tablet once daily with water, regardless of meals. It is recommended to take it at the same time every day, if possible (e.g., in the morning). Before administering the telmisartan/amlodipine combination, it is recommended to adjust the doses of each individual component; however, if blood pressure is not controlled, conversion to the combination can be considered. - 40/5 mg: Given to patients whose blood pressure is not controlled with amlodipine 5 mg or telmisartan 40 mg.

This medication can cause serious harm or death to the fetus and newborn if given to pregnant women, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to any component of this medication or similar drugs should not take it. In particular, patients with hereditary angioedema or a history of angioedema should not use this medication. Pregnant women, women of childbearing potential, and nursing mothers should not take this medication and should use appropriate contraception. Patients with severe liver dysfunction or bile excretion issues should not take this medication. Patients with severe renal impairment, severe aortic stenosis, patients in shock, and patients with myopathy should also not use this medication. Patients with diabetes or moderate to severe renal impairment should be cautious as certain components may pose risks when used together. Elderly patients, those with hypotension, patients with hyperkalemia, and those with mild liver dysfunction should take this medication cautiously, and dosage adjustments may be necessary. This medication can cause muscle-related side effects, such as myalgia, myopathy, and rhabdomyolysis, so patients should consult a doctor immediately if symptoms like muscle pain or weakness occur. Liver function issues may occur, so regular liver function tests should be conducted before and during treatment. This medication may interact with other drugs, so patients should inform healthcare providers about any other medications they are taking. Nursing women should not take this medication, and if unavoidable, breastfeeding should be discontinued. Safety and efficacy in pediatric patients have not been adequately verified, so it is not recommended for use in children. In the case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, so immediate medical attention should be sought and appropriate treatment given. This medication should be kept out of reach of children and it is advisable not to transfer it to another container.

Serious side effects

Urticaria, angioedema, severe swelling, unstable angina, intravascular volume depletion, hypotension, syncope, cold sweat, pallor, chest tightness, difficulty breathing, severe allergic reactions, severe skin reactions, severe rash, blisters, peeling skin, oral/ocular mucosal pain, dyspnea, asthma attacks, respiratory issues accompanied by cough and fever, jaundice, liver abnormalities, sudden and severe headache, thunderclap headache, seizures, confusion

Mild side effects

• Headache
• dizziness
• weakness
• cough
• nausea
• fatigue
• malaise
• edema
• peripheral edema
• angioedema

This medication should be stored in a tightly closed container that can block light, at room temperature between 1 and 30 degrees Celsius. Storing it this way helps to maintain the medication's efficacy and prevent degradation.

Appearance

An oval two-layer tablet consisting of a white layer and a light blue layer.

Package unit

30 tablets (10 tablets/PTP x 3)